Literature DB >> 3128612

Transcriptional regulation of mu and delta gene expression in bone marrow pre-B and B lymphocytes.

D Yuan1, P L Witte.   

Abstract

Newly formed B cells first express IgM and subsequently display IgD on the cell surface. This is an ontologically, as well as developmentally, regulated process because IgD is virtually absent on neonatal splenic B cells. In the present studies we have examined, by means of nascent RNA chain labeling, the relative levels of mu to delta gene transcription in bone marrow B cells, pre-B cells, and earlier progenitors of B cells. Pre-B cells were obtained from Whitlock-type long term cultures of bone marrow cells from normal and C.B17 scid mice. Both populations were found to transcribe the delta gene at very low but detectable levels. A similarly low level of delta transcription was found to occur in surface IgM-positive cells from both cultured and freshly isolated bone marrow B cells. In all populations analyzed, termination of the majority of polymerases occurred within a discrete 1-kb region located between the microM and C delta I exons. Analysis of steady state RNA indicated that long term cultured bone marrow cells from normal mice produced both 2.7-kb normal sized microM mRNA as well as 2.9-kb aberrantly spliced I mu-mRNA, whereas those from C.B17 scid mice contained only aberrant sized mu-mRNA. In contrast to these results, our previous findings with spleen cells obtained from both neonatal and adult animals showed that delta gene transcription occurs at a relatively high level. Therefore, it is possible that activation of regulatory signals that allow polymerases to progress beyond the termination site 3' of the microM exons may occur when newly formed B cells migrate from the bone marrow to the splenic environment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128612

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.

Authors:  F Loder; B Mutschler; R J Ray; C J Paige; P Sideras; R Torres; M C Lamers; R Carsetti
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

2.  An RNA polymerase pause site is associated with the immunoglobulin mus poly(A) site.

Authors:  Martha L Peterson; Shannon Bertolino; Frankie Davis
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

3.  Parameters that govern the regulation of immunoglobulin delta heavy-chain gene expression.

Authors:  R Tisch; N Kondo; N Hozumi
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

4.  Zinc-finger protein ZFP318 is essential for expression of IgD, the alternatively spliced Igh product made by mature B lymphocytes.

Authors:  Anselm Enders; Alanna Short; Lisa A Miosge; Hannes Bergmann; Yovina Sontani; Edward M Bertram; Belinda Whittle; Bhavani Balakishnan; Kaoru Yoshida; Geoff Sjollema; Matthew A Field; T Daniel Andrews; Hiromi Hagiwara; Christopher C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

5.  Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens.

Authors:  L Nitschke; M H Kosco; G Köhler; M C Lamers
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

6.  Regulatory elements necessary for termination of transcription within the Ig heavy chain gene locus.

Authors:  B B Moore; J Tan; P L Lim; P W Tucker; D Yuan
Journal:  Nucleic Acids Res       Date:  1993-03-25       Impact factor: 16.971

7.  Feedback inhibition of immunoglobulin gene rearrangement by membrane mu, but not by secreted mu heavy chains.

Authors:  J Manz; K Denis; O Witte; R Brinster; U Storb
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

8.  Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen.

Authors:  R Brink; C C Goodnow; J Crosbie; E Adams; J Eris; D Y Mason; S B Hartley; A Basten
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.